Mattias Beltinga and colleagues showed that microvesicles derived from hypoxic glioblastoma (GBM) cells carry tissue factor and factor VIIa with the potential to activate protease-activated receptor 2, which was found to elicit an angiogenic phenotype of endothelial cells [57]. The gene discussed is F2RL1; the disease is glioblastoma.